These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16416445)

  • 1. Alterations in alcohol consumption, withdrawal seizures, and monoamine transmission in rats treated with phentermine and 5-hydroxy-L-tryptophan.
    Halladay AK; Wagner GC; Sekowski A; Rothman RB; Baumann MH; Fisher H
    Synapse; 2006 Apr; 59(5):277-89. PubMed ID: 16416445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of phentermine and fenfluramine on alcohol consumption and alcohol withdrawal seizures in rats.
    Halladay AK; Fisher H; Wagner GC
    Alcohol; 2000 Jan; 20(1):19-29. PubMed ID: 10680713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of monoaminergic agonists on alcohol intake in rats fed a tryptophan-enhanced diet.
    Halladay AK; Wagner GC; Hsu T; Sekowski A; Fisher H
    Alcohol; 1999 May; 18(1):55-64. PubMed ID: 10386666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethanol, 3,4-methylenedioxymethamphetamine (ecstasy) and their combination: long-term behavioral, neurochemical and neuropharmacological effects in the rat.
    Cassel JC; Riegert C; Rutz S; Koenig J; Rothmaier K; Cosquer B; Lazarus C; Birthelmer A; Jeltsch H; Jones BC; Jackisch R
    Neuropsychopharmacology; 2005 Oct; 30(10):1870-82. PubMed ID: 15785779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethanol desensitizes cannabinoid CB1 receptors modulating monoamine synthesis in the rat brain in vivo.
    Moranta D; Esteban S; García-Sevilla JA
    Neurosci Lett; 2006 Jan; 392(1-2):58-61. PubMed ID: 16183202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotoxic effects of +/-fenfluramine and phenteramine, alone and in combination, on monoamine neurons in the mouse brain.
    McCann UD; Yuan J; Ricaurte GA
    Synapse; 1998 Nov; 30(3):239-46. PubMed ID: 9776127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phentermine and fenfluramine. Preclinical studies in animal models of cocaine addiction.
    Rothman RB; Elmer GI; Shippenberg TS; Rea W; Baumann MH
    Ann N Y Acad Sci; 1998 May; 844():59-74. PubMed ID: 9668665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Hydroxy-tryptophan for the treatment of L-DOPA-induced dyskinesia in the rat Parkinson's disease model.
    Tronci E; Lisci C; Stancampiano R; Fidalgo C; Collu M; Devoto P; Carta M
    Neurobiol Dis; 2013 Dec; 60():108-14. PubMed ID: 24004632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine increases the anorectic and long-term dopamine-depleting effects of phentermine.
    Callahan BT; Yuan J; Ricaurte GA
    Synapse; 2000 Dec; 38(4):471-6. PubMed ID: 11044894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual differences in ethanol self-administration following withdrawal are associated with asymmetric changes in dopamine and serotonin in the medial prefrontal cortex and amygdala.
    Carlson JN; Drew Stevens K
    Alcohol Clin Exp Res; 2006 Oct; 30(10):1678-92. PubMed ID: 17010135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anorectic interaction and safety of 5-hydroxytryptophan/carbidopa plus phentermine or diethylpropion in rat.
    Limón-Bernal E; Roa-Coria JE; Zúñiga-Romero Á; Huerta-Cruz JC; Ruíz-Velasco IRC; Flores-Murrieta FJ; Lara-Padilla E; Reyes-García JG; Rocha-González HI
    Behav Pharmacol; 2021 Aug; 32(5):368-381. PubMed ID: 33660661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of phentermine plus fenfluramine: neurochemical and neurotoxic effects.
    Halladay AK; Fisher H; Wagner GC
    Neurotoxicology; 1998 Apr; 19(2):177-83. PubMed ID: 9553954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethanol exposure differentially alters central monoamine neurotransmission in alcohol-preferring versus -nonpreferring rats.
    Smith AD; Weiss F
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1223-8. PubMed ID: 10027862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin (5-HT) precursor loading with 5-hydroxy-l-tryptophan (5-HTP) reduces locomotor activation produced by (+)-amphetamine in the rat.
    Baumann MH; Williams Z; Zolkowska D; Rothman RB
    Drug Alcohol Depend; 2011 Apr; 114(2-3):147-52. PubMed ID: 21071157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving rats.
    Rowley HL; Butler SA; Prow MR; Dykes SG; Aspley S; Kilpatrick IC; Heal DJ
    Synapse; 2000 Nov; 38(2):167-76. PubMed ID: 11018791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressants attenuate both the enhanced ethanol intake and ethanol-induced anxiolytic effects in diazepam withdrawn rats.
    Martijena ID; Bustos SG; Bertotto ME; Molina VA
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):119-30. PubMed ID: 15572281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoaminergic changes associated with audiogenic seizures in ethanol-dependent rats.
    Yu L; Fisher H; Wagner GC
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Nov; 24(8):1379-92. PubMed ID: 11125861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice.
    Ago Y; Nakamura S; Uda M; Kajii Y; Abe M; Baba A; Matsuda T
    Neuropharmacology; 2006 Sep; 51(4):914-22. PubMed ID: 16863654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-administration of amphetamine with alcohol results in decreased alcohol withdrawal severity in adolescent rats.
    Popkin S; Nanchanatt A; Mauterer MI; Rhoads DE
    Behav Pharmacol; 2018 Sep; 29(6):547-550. PubMed ID: 29595541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.